ClinicalTrials.gov
ClinicalTrials.gov Menu

Cisplatin + RT for Triple Negative Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01674842
Recruitment Status : Recruiting
First Posted : August 29, 2012
Last Update Posted : July 26, 2017
Sponsor:
Information provided by (Responsible Party):
Jennifer Bellon, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 2018
  Estimated Study Completion Date : October 2023